MARTIN LINDMAN — Doktor.se
EBITDA of minus 147 million. An IPO that never happened. A pandemic in the middle of the build-up. Martin Lindman went from professional hockey player to building one of Europe's largest digital healthcare companies — and today Doktor.se has revenue of SEK 1.8 billion, is cash-flow positive and has made four acquisitions in a single year.
In this episode we talk about what actually cracked the code, what it was like to be forced to put the listing plans on ice, and why Nasdaq in 2026 is the goal — and what that means for investors who get in before then.
Doktor.se shares can be traded on the unlisted secondary market through Eqvor HERE.
